WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2016091776) 1,3-THIAZOL-2-YL SUBSTITUTED BENZAMIDES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2016/091776    International Application No.:    PCT/EP2015/078765
Publication Date: 16.06.2016 International Filing Date: 07.12.2015
IPC:
C07D 417/12 (2006.01), C07D 417/14 (2006.01), A61K 31/4439 (2006.01), A61K 31/497 (2006.01), A61K 31/501 (2006.01), A61K 31/506 (2006.01), A61K 31/433 (2006.01), A61P 13/00 (2006.01), A61P 29/00 (2006.01), A61P 31/18 (2006.01), A61P 25/16 (2006.01), A61P 25/28 (2006.01)
Applicants: BAYER AKTIENGESELLSCHAFT [DE/DE]; Kaiser-Wilhelm-Allee 1 51373 Leverkusen (DE)
Inventors: DAVENPORT, Adam James; (GB).
BRAEUER, Nico; (DE).
FISCHER, Oliver Martin; (DE).
ROTGERI, Andrea; (DE).
ROTTMANN, Antje; (DE).
NEAGOE, Ioana; (DE).
NAGEL, Jens; (DE).
GODINHO-COELHO, Anne-Marie; (DE)
Agent: BÜCHEL, Edwin; (DE)
Priority Data:
14196954.3 09.12.2014 EP
Title (EN) 1,3-THIAZOL-2-YL SUBSTITUTED BENZAMIDES
(FR) BENZAMIDES À SUBSTITUTION 1,3-THIAZOL-2-YL
Abstract: front page image
(EN)The present invention relates to 1,3-thiazol-2-yl substituted benzamide compounds of general formula (I) as described and defined herein, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of neurogenic disorder, as a sole agent or in combination with other active ingredients.
(FR)La présente invention concerne des composés benzamide à substitution 1,3-thiazol-2-yl de formule générale (I) décrite et définie dans la description, des compositions pharmaceutiques et des associations comprenant lesdits composés et l'utilisation desdits composés pour la fabrication d'une composition pharmaceutique destinée au traitement ou à la prophylaxie d'une maladie, en particulier d'un trouble neurogène, en tant qu'agent unique ou en association avec d'autres principes actifs.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)